|
Volumn 26, Issue 8, 2015, Pages 1251-
|
Re: Safety and efficacy of 70-150 μm and 100-300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma
a b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DRUG CARRIER;
DRUG ELUTING BEAD;
UNCLASSIFIED DRUG;
DELAYED RELEASE FORMULATION;
ACUTE CHOLECYSTITIS;
ASCITES;
BILOMA;
BRAIN DISEASE;
CHEMOEMBOLIZATION;
CHOLECYSTITIS;
CHOLESTASIS;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SAFETY;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
LENGTH OF STAY;
LETTER;
LIVER ABSCESS;
LIVER CELL CARCINOMA;
LIVER FAILURE;
PORTAL VEIN THROMBOSIS;
PRIORITY JOURNAL;
ADMINISTRATION AND DOSAGE;
CARCINOMA, HEPATOCELLULAR;
DELAYED RELEASE FORMULATION;
FEMALE;
LIVER NEOPLASMS;
MALE;
PROCEDURES;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
CHEMOEMBOLIZATION, THERAPEUTIC;
DELAYED-ACTION PREPARATIONS;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
MALE;
|
EID: 84938075545
PISSN: 10510443
EISSN: 15357732
Source Type: Journal
DOI: 10.1016/j.jvir.2015.04.027 Document Type: Letter |
Times cited : (3)
|
References (4)
|